Difference between revisions of "Lin Sheng-Cai"
From Bioblast
Beno Marija (talk | contribs) (Created page with "{{person}}") Β |
m (Gnaiger Erich moved page Lin SC to Lin Sheng-Cai over redirect) Β |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Person | ||
|lastname=Lin | |||
|firstname=Sheng-Cai | |||
|title=Prof. | |||
|institution=School of Life Sciences, | |||
Β | |||
Xiamen University, CN | |||
|address=School of Life Sciences, Xiang'an Campus, Xiamen University, Xiang'an District | |||
|area code=361102 | |||
|city=Xiamen, Fujian Province | |||
|country=China | |||
}} | |||
{{Labelingperson}} |
Latest revision as of 05:32, 1 March 2020
Name | Lin Sheng-Cai, Prof. |
---|---|
Institution | School of Life Sciences,
Xiamen University, CN |
Address | School of Life Sciences, Xiang'an Campus, Xiamen University, Xiang'an District, 361102 |
City | Xiamen, Fujian Province |
State/Province | |
Country | China |
[email protected] | |
Weblink | |
O2k-Network Lab | CN Xiamen Lin SC |
Labels:
Publications
Published | Reference | |
---|---|---|
Zhang 2022 Nat Metab | 2022 | Zhang CS, Li M, Wang Y, Li X, Zong Y, Long S, Zhang M, Feng JW, Wei X, Liu YH, Zhang B, Wu J, Zhang C, Lian W, Ma T, Tian X, Qu Q, Yu Y, Xiong J, Liu DT, Wu Z, Zhu M, Xie C, Wu Y, Xu Z, Yang C, Chen J, Huang G, He Q, Huang X, Zhang L, Sun X, Liu Q, Ghafoor A, Gui F, Zheng K, Wang W, Wang ZC, Yu Y, Zhao Q, Lin SY, Wang ZX, Piao HL, Deng X, Lin SC (2022) The aldolase inhibitor aldometanib mimics glucose starvation to activate lysosomal AMPK. https://doi.org/10.1038/s42255-022-00640-7 |
Lee 2018 Reprod Sci | 2018 | Lee HC, Lin SC, Wu MH, Tsai SJ (2018) Induction of pyruvate dehydrogenase kinase 1 by hypoxia alters cellular metabolism and inhibits apoptosis in endometriotic stromal cells. Reprod Sci 26:734-44. |